Cite
HARVARD Citation
Whelton, A. et al. (n.d.). SAT0094 Celecoxib does not increase the risk of cardiac failure, oedema, or hypertension compared to nsaids: results from success 1, a double blind, randomised trial in 13, 274 oa patients. Annals of the rheumatic diseases. p. A186. [Online].